Evonik Opens New GMP-Certified Manufacturing Plant in Vancouver
Evonik has opened a new GMP-certified manufacturing plant in Vancouver to expand its capacity for lipid-based drug delivery. The facility addresses the growing demand for nanoparticle development.
Evonik has opened a new manufacturing plant in Vancouver, Canada, certified under Good Manufacturing Practices (GMP). This expansion increases the company's capacity for producing lipid-based drug delivery systems.
The facility is designed to meet the increasing demand for the development and manufacturing of nanoparticle solutions. These technologies are crucial for the targeted delivery of new drugs and vaccines within the body.
The new plant supports Evonik's strategy to broaden its drug development services. The company aims to strengthen its role as a partner for pharmaceutical and biotechnology firms.
The Vancouver location provides strategic advantages in terms of accessibility and expertise. The plant's construction is part of Evonik's wider investment in advanced materials and drug delivery technologies.